Ontology highlight
ABSTRACT: Background
The establishment of patient-derived models for pancreatic ductal adenocarcinoma (PDAC) using conventional methods has been fraught with low success rate, mainly because of the small number of tumour cells and dense fibrotic stroma. Here, we sought to establish patient-derived model of PDAC and perform genetic analysis with responses to anticancer drug by using the conditionally reprogrammed cell (CRC) methodology.Methods
We performed in vitro and in vivo tumourigenicity assays and analysed histological characteristics by immunostaining. We investigated genetic profiles including mutation patterns and copy number variations using targeted deep sequencing and copy-number analyses. We assessed the responses of cultured CRCs to the available clinical anticancer drugs based on patient responsiveness.Findings
We established a total of 28 CRCs from patients. Of the 28 samples, 27 showed KRAS mutations in codon 12/13 or codon 61. We found that somatic mutations were shared in the primary-CRC pairs and shared mutations included key oncogenic mutations such as KRAS (9 pairs), TP53 (8 pairs), and SMAD4 (3 pairs). Overall, CRCs preserved the genetic characteristics of primary tumours with high concordance, with additional confirmation of low-AF NPM1 mutation in CRC (35 shared mutations out of 36 total, concordance rate=97.2%). CRCs of the responder group were more sensitive to anticancer agents than those of the non-responder group (P < 0.001).Interpretation
These results show that a pancreatic cancer cell line model can be efficiently established using the CRC methodology, to better support a personalized therapeutic approach for pancreatic cancer patients.Funding
2014R1A1A1006272, HI19C0642-060019, 2019R1A2C2008050, 2020R1A2C209958611, and 2020M3E5E204028211.
SUBMITTER: Lee HS
PROVIDER: S-EPMC7921470 | biostudies-literature | 2021 Feb
REPOSITORIES: biostudies-literature
Lee Hee Seung HS Kim Eunyoung E Lee Jinyoung J Park Seung Joon SJ Hwang Ho Kyoung HK Park Chan Hee CH Jo Se-Young SY Kang Chang Moo CM Hong Seung-Mo SM Kang Huapyong H Jo Jung Hyun JH Cho In Rae IR Chung Moon Jae MJ Park Jeong Youp JY Park Seung Woo SW Song Si Young SY Han Jung Min JM Kim Sangwoo S Bang Seungmin S
EBioMedicine 20210225
<h4>Background</h4>The establishment of patient-derived models for pancreatic ductal adenocarcinoma (PDAC) using conventional methods has been fraught with low success rate, mainly because of the small number of tumour cells and dense fibrotic stroma. Here, we sought to establish patient-derived model of PDAC and perform genetic analysis with responses to anticancer drug by using the conditionally reprogrammed cell (CRC) methodology.<h4>Methods</h4>We performed in vitro and in vivo tumourigenici ...[more]